Stockreport

Roche launches new Elevidys study after feedback from European regulator [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF The therapy for duchenne muscular dystrophy (DMD), for which Roche partners ?with American Sarepta Therapeutics, had failed to win backing from the European Medicines Ag [Read more]